SunBio,Inc. (KOSDAQ: 067370)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,600.00
-30.00 (-0.39%)
Dec 19, 2024, 9:00 AM KST

SunBio,Inc. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2014 FY 2013
Period Ending
Dec '14 Dec '14 Dec '13
Revenue
2,1712,1712,122
Revenue Growth (YoY)
-2.28%-
Cost of Revenue
940.23940.23678.71
Gross Profit
1,2311,2311,444
Selling, General & Admin
778.26778.26673
Other Operating Expenses
65.9965.99164.19
Operating Expenses
881.34881.34836.15
Operating Income
349.26349.26607.5
Interest Expense
-22.71-22.71-40.31
Interest & Investment Income
82.3382.3392.64
Currency Exchange Gain (Loss)
-0.05-0.0569.95
Other Non Operating Income (Expenses)
1.961.960.16
EBT Excluding Unusual Items
410.79410.79729.94
Gain (Loss) on Sale of Investments
5.45.4-
Gain (Loss) on Sale of Assets
1,0881,088-
Pretax Income
1,5041,504729.94
Income Tax Expense
109.82109.8281.98
Net Income
1,3941,394647.96
Net Income to Common
1,3941,394647.96
Net Income Growth
-115.16%-
Shares Outstanding (Basic)
666
Shares Outstanding (Diluted)
666
Shares Change (YoY)
-0.10%-
EPS (Basic)
249.33249.33116.00
EPS (Diluted)
249.33249.33116.00
EPS Growth
-114.94%-
Free Cash Flow
-868.06-868.06769.8
Free Cash Flow Per Share
-155.24-155.24137.81
Gross Margin
56.69%56.69%68.02%
Operating Margin
16.09%16.09%28.62%
Profit Margin
64.22%64.22%30.53%
Free Cash Flow Margin
-39.99%-39.99%36.27%
EBITDA
403.98403.98698.02
EBITDA Margin
18.61%18.61%32.89%
D&A For EBITDA
54.7154.7190.52
EBIT
349.26349.26607.5
EBIT Margin
16.09%16.09%28.62%
Effective Tax Rate
7.30%7.30%11.23%
Source: S&P Capital IQ. Standard template. Financial Sources.